User Experience of a Telemedicine Platform for the Follow-up of Post Intensive Care Syndrome (PICS)

NCT06438380 | Not Yet Recruiting

• 1 other identifier: 2023/5126
• Study Type: observational
• Target: 14
• Locations: 0 countries
• Sites: N/A

Brief Summary

Survivors of critical illness may present with a set of physical, emotional and cognitive sequelae, known as Post Intensive Care Syndrome (PICS). These alterations can become chronic over time and significantly affect patients' quality of life. Therefore, follow-up and monitoring of critically ill patients after ICU discharge, for example through telemedicine, could be essential for the prevention, early detection and management of PICS. Our main objective is to evaluate the suitability and user experience of a telemedicine platform from the perspective of critically ill patients. This study proposes the participation of ICU survivors in the design and improvement of a telemedicine platform for PICS follow-up through a qualitative approach. Participants will test the platform in person three months after discharge from the ICU and then undergo a semi-structured interview to assess their experience. The findings derived from this study may contribute to improve both the content and the format of the platform, optimizing resources and facilitating the management of post-ICU sequelae, which will have a positive impact on the patient's recovery process.

Conditions

Critical Illness

Keywords

Qualitative research; Post-Intensive Care Syndrome

Outcome Measures

Primary Outcomes (1)

• 1:1 semi-structured interviews

  To evaluate the user experience of a telemedicine platform for monitoring post-intensive care syndrome from the perspective of critically ill patients after ICU discharge through semi-structured interviews

  3 months after ICU discharge

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Critically ill patients admitted to the ICU of the Parc Tauli Hospital (Sabadell, Spain).

You may qualify if:

• Adult patients (≥18 years)
• Admitted to a medical/surgical ICU
• For respiratory failure, cardiogenic shock, or septic shock
• With an expected ICU stay of ≥48 hours
• Catalan and/or Spanish speakers
• Who are able to give informed consent by themselves

You may not qualify if:

• History of intellectual disability or other neurodevelopmental disorders, such as autism spectrum disorder
• History of neurological disorders, dementia or other neurodegenerative diseases, such as epilepsy, Alzheimer's disease, Parkinson's disease or multiple sclerosis
• History of brain damage, such as traumatic brain injury or stroke
• History of severe psychiatric illness, such as psychotic, bipolar, depressive, obsessive-compulsive, post-traumatic or personality disorder
• Suspected or confirmed substance use disorder
• Suspected or confirmed communicable disease in an isolated patient
• Uncorrected hearing or visual impairment
• Enrolled in another trial that does not allow co-enrollment

Sponsors & Collaborators

• Corporacion Parc Tauli: lead

MeSH Terms

Conditions

Critical Illness; postintensive care syndrome

Condition Hierarchy (Ancestors)

Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Marta Godoy-González, PhD student

CONTACT

+34937236673; mrgodoy@tauli.cat

Sol Fernández-Gonzalo, PhD

CONTACT

+34937236673; msfernandez@tauli.cat

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 27, 2024
• First Posted: May 31, 2024
• Study Start: May 1, 2024
• Primary Completion: December 1, 2024
• Study Completion: December 1, 2024
• Last Updated: May 31, 2024

Record last verified: 2024-05